Physician profile
Michael Scott
NPI 1669797031
$8,320.95
in general payments reported to CMS, 2019-2025
17 companies · $967 in 2025
The $967 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $2,435 · 2021: $1,358 · 2022: $801 · 2023: $678 · 2024: $1,385 · 2025: $967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,030.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,823.57 | 2020-2024 | |
| Arthrex, INC. | $1,731.12 | 2020 | |
| Zimmer Biomet Holdings, INC. | $1,559.98 | 2019-2025 | Tapestry, Persona, Juggerknotless Soft Anchor |
| Stryker Corporation | $1,035.29 | 2020-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Avanos Medical | $706.17 | 2019-2024 | On-Q* Pump and Accessories |
| Smith+Nephew, INC. | $246.20 | 2019-2022 | |
| Kerecis Limited | $169.09 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bone Support INC. | $156.42 | 2024 | Cerament G, Ceramentbone Void Filler |
| Innovation Technologies INC | $145.41 | 2022 | |
| Depuy Synthes Sales INC. | $124.80 | 2019 | |
| Heron Therapeutics, INC. | $121.35 | 2024 | Zynrelef |
| Davol INC. | $119.48 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $118.42 | 2022 | |
| Pacira Therapeutics, INC. | $102.50 | 2019 | |
| Kci USA, INC. | $96.67 | 2023 | V.A.C. Veraflo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $47.80 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $16.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.